|
|
Volumn 95, Issue 10, 1997, Pages 2335-
|
|
Cardiovascular and renal advisory panel of the US Food and Drug Administration considers four drugs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
CARVEDILOL;
DIGITALIS;
DIURETIC AGENT;
ENALAPRIL;
EPTIFIBATIDE;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
MIBEFRADIL;
UNCLASSIFIED DRUG;
ANGINA PECTORIS;
CONGESTIVE HEART FAILURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INFORMATION;
DRUG LABELING;
HEART INFARCTION;
HEART MUSCLE POTENTIAL;
HYPERTENSION;
MORTALITY;
NOTE;
PATIENT SELECTION;
PRIORITY JOURNAL;
SURVIVAL RATE;
THROMBOCYTE FUNCTION;
TREATMENT INDICATION;
|
|
EID: 0030972175
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.95.10.2335 Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|
